Mice lacking Y1 receptor in the hematopoietic compartment remain healthy under normal chow feeding conditions. Mice lacking Y1 receptor in the hematopoietic.

Slides:



Advertisements
Similar presentations
The FATZO mouse as a Translational Model for the Development of Drugs for Obesity, Metabolic Syndrome and Diabetes. PreClinOmics, Inc. 1.
Advertisements

Receipts’ Blood Receipts’ Bone Marrow Receipt’s Spleen
Figure Legend: From: High-Fat Diet–Induced Retinal Dysfunction
Arterioscler Thromb Vasc Biol
Volume 4, Issue 12, Pages (December 2015)
Volume 10, Issue 4, Pages (October 2009)
Genes Within the MHC Region Have a Dramatic Influence on Radiation-Enhanced Atherosclerosis in MiceClinical Perspective by Weibin Shi, Zhimin Zhang, Mei-Hua.
Volume 88, Issue 1, Pages (January 1997)
Volume 16, Issue 10, Pages (September 2016)
Volume 15, Issue 2, Pages (February 2012)
Volume 23, Issue 1, Pages (January 2016)
Fig. 4. The effects of AVP or d(Leu4Lys8)VP, a specific AVPR1B agonist, on anemic rodents. The effects of AVP or d(Leu4Lys8)VP, a specific AVPR1B agonist,
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Impaired glucose tolerance in adult S1/3 KO mice on a normal chow
Volume 20, Issue 1, Pages (July 2014)
Volume 19, Issue 1, Pages (January 2014)
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Volume 1, Issue 1, Pages (January 2005)
Treatment with AAV8‐hAAT‐FGF21 improves insulin sensitivity and glucose tolerance Treatment with AAV8‐hAAT‐FGF21 improves insulin sensitivity and glucose.
Volume 10, Issue 5, Pages (November 2009)
Volume 9, Issue 1, Pages (January 2009)
Volume 1, Issue 4, Pages (April 2005)
Volume 6, Issue 3, Pages (September 2007)
Volume 14, Issue 4, Pages (October 2011)
Volume 96, Issue 3, Pages (February 1999)
Roles for leptin receptor/STAT3-dependent and -independent signals in the regulation of glucose homeostasis  Sarah H. Bates, Rohit N. Kulkarni, Matthew.
Volume 14, Issue 5, Pages (November 2011)
Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice  Decheng Ren, Minghua Li, Chaojun Duan, Liangyou.
Exosomes transfected with obesity-associated miRNAs induce glucose intolerance dissociated from obesity. Exosomes transfected with obesity-associated miRNAs.
Deletion of neuronal insulin receptor signaling reduces TG secretion, while the targeted knockout of insulin receptors restricted to the periphery increases.
Exogenous CRP administration causes fasting hyperglycemia and hyperinsulinemia without altering body composition. Exogenous CRP administration causes fasting.
1018-NT-β-cell clusters protect mice from STZ-induced diabetes.
WASH cKO mice display a normal pancreatic development.
Chronic brain insulin infusion reduces liver TG content independent of changes in body weight and food intake. Chronic brain insulin infusion reduces liver.
TG-CRP mice display fasting hyperglycemia, hyperinsulinemia, and insulin resistance. TG-CRP mice display fasting hyperglycemia, hyperinsulinemia, and insulin.
GSIS. GSIS. In vivo: serum insulin levels at fasting state and 30 min after glucose injection (A) and the fold change in serum insulin after glucose loading.
Volume 4, Issue 5, Pages (November 2006)
GLUT4 LXRE is required for downregulation of adipose GLUT4 mRNA during fasting and diet-induced obesity. GLUT4 LXRE is required for downregulation of adipose.
Guinea pigs fed HFHC diet develop impaired glucose tolerance and suppressed response to insulin. Guinea pigs fed HFHC diet develop impaired glucose tolerance.
Modulation of insulin sensitivity by IL-6 in mice: A lack of PTP1B prevents chronic effects of IL-6. Modulation of insulin sensitivity by IL-6 in mice:
Glucose tolerance in WT and TRPM2-KO mice.
Transgenic restoration of long-chain n-3 PUFA protects against obesity-linked insulin resistance and glucose intolerance. Transgenic restoration of long-chain.
ΑGLP-1R−/− mice show glucose intolerance and disturbed glucagon secretion in response to i.p. glucose administration. αGLP-1R−/− mice show glucose intolerance.
Effects of the β-cell–specific expression of mKL on blood glucose levels, glucose tolerance, insulin sensitivity, and plasma insulin levels in STZ-induced.
GLP-1 and gastrin combination therapy restores normoglycemia in NOD mice. GLP-1 and gastrin combination therapy restores normoglycemia in NOD mice. Beginning.
A: Chemical structure of pterosin A
Chop deletion preserves β-cell function in P58IPK−/− mice.
Rapid improvement of glucose tolerance induced by PP
Adoptive transfer of purified activated G9Cα−/−
AgRP-ATF4 KO mice have decreased food intake and enhanced energy expenditure. AgRP-ATF4 KO mice have decreased food intake and enhanced energy expenditure.
Metabolic parameters of Id1−/− and wild-type mice fed a standard chow diet (hatched bars and striped bars, respectively) or a high-fat diet (black bars.
USP2–45 regulates hepatic gluconeogenesis.
Effect of Id1 deletion on insulin action in wild-type and Id1−/− mice fed a chow diet (white triangle/striped bar and black triangle/hatched bar, respectively)
Effect of anandamide on blood glucose clearance and insulin sensitivity. Effect of anandamide on blood glucose clearance and insulin sensitivity. A: Intraperitoneal.
Mice fed GP-SPI diet show improved fasting glucose and oral glucose tolerance. Mice fed GP-SPI diet show improved fasting glucose and oral glucose tolerance.
Hepatic PPARγ deficiency impairs the SCFA-induced reduction in hepatic steatosis. Hepatic PPARγ deficiency impairs the SCFA-induced reduction in hepatic.
Insulin resistance and hepatic steatosis in ASKO mice.
Effects of Rosi treatment on ASKO mice.
Effects of chow-diet feeding on control and TRIB3 MOE mice.
Effects of berberine on in vivo metabolism in two animal models of insulin resistance. Effects of berberine on in vivo metabolism in two animal models.
GTTs and ITTs. A: GTTs of WT (◇), LepTg (♦), Akita (open circles), and LepTg:Akita (closed circles) mice at 8 and 16 weeks of age. GTTs and ITTs. A: GTTs.
High-fat diet–induced glucose intolerance is prevented in ghrelin knockout (Ghr-KO) mice. High-fat diet–induced glucose intolerance is prevented in ghrelin.
Loss of Phb2 in β-cells induces development of diabetes over a 3-week period in β-Phb2−/− mice. Loss of Phb2 in β-cells induces development of diabetes.
β-Cell–specific deletion of Phb2 renders mice diabetic.
Increased pancreatic insulin content and islet size and protection against HFD- and palmitate-induced cell death in PKCδKN-overexpressing mice. Increased.
Inducible liver-specific insulin receptor knockout (iLIRKO) shows insulin resistance in the liver and extrahepatic tissues. Inducible liver-specific insulin.
Deficiency of adipocyte IKKβ does not affect diet-induced weigh gain but results in an exaggerated diabetic phenotype when challenged with an HFD. A: IKKβ.
EPA+DHA supplementation does not alter body composition, body weight, or feed intake. EPA+DHA supplementation does not alter body composition, body weight,
Fig. 1. GDF15 is up-regulated with obesity, and AAV-GDF15 improves metabolic parameters in DIO mice. GDF15 is up-regulated with obesity, and AAV-GDF15.
Fig. 3. Effects of SFN in mice with diet-induced diabetes.
Presentation transcript:

Mice lacking Y1 receptor in the hematopoietic compartment remain healthy under normal chow feeding conditions. Mice lacking Y1 receptor in the hematopoietic compartment remain healthy under normal chow feeding conditions. A: DNA from the indicated tissues was extracted from C57BL/6 (BL6) mice, or from irradiated C57BL/6 mice that had been reconstituted with bone marrow from either Y1KO or wild-type mice, termed Y1BM or CTBM, respectively. A PCR product of 750 bp indicates no Y1 gene deletion, and a 520-bp product indicates Y1 gene deletion. Mouse genomic DNA and water were used as positive (+) and negative (−) controls, respectively. B: Body weight of normal, chow-fed CTBM and Y1BM from 14 to 29 weeks of age, as indicated as 0–15 weeks on the x-axis. C: Food intake (grams per gram of mouse body weight) of 29-week-old CTBM and Y1BM mice on a normal chow diet. Blood glucose concentration in response to intraperitoneal injection of 1 unit/kg insulin after a 5-h fast (D) or 1 g/kg glucose after a 16-h fast (E) in normal, chow-fed CTBM and Y1BM mice at 29–30 weeks of age. Data are means ± SEM of three to four female mice per group. Laurence Macia et al. Diabetes 2012;61:3228-3238 ©2012 by American Diabetes Association